Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193805-21-000212
Filing Date
2021-02-12
Accepted
2021-02-12 12:39:17
Documents
1
Group Members
DEERFIELD MANAGEMENT COMPANY, L.P.DEERFIELD MGMT, L.P.DEERFIELD PARTNERS, L.P.DEERFIELD SPECIAL SITUATIONS FUND, L.P.

Document Format Files

Seq Description Document Type Size
1 e620285_sc13ga-x4.htm SC 13G/A 116243
  Complete submission text file 0001193805-21-000212.txt   117804
Mailing Address 780 THIRD AVENUE 37TH FLOOR NEW YORK NY 10017
Business Address
Flynn James E (Filed by) CIK: 0001352546 (see all company filings)

Type: SC 13G/A

Mailing Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134
Business Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134 857-529-8300
X4 Pharmaceuticals, Inc (Subject) CIK: 0001501697 (see all company filings)

EIN.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90199 | Film No.: 21624851
SIC: 2836 Biological Products, (No Diagnostic Substances)